Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR1 | P30989 | 3/20 | 0.47 |
| ▸ | F2 | P00734 | 4/20 | 0.46 |
| ▸ | NPY2R | P49146 | 7/20 | 0.46 |
| ▸ | NPY4R | P50391 | 7/20 | 0.46 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.46 |
| ▸ | NPY1R | P25929 | 5/20 | 0.46 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.45 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.44 |
| ▸ | CALCR | P30988 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30286103 | 0.83 | CAPN1 (0.43) | NTSR1NPY2RNPY4RNPY5RNPY1R | |
| Larazotide SCHEMBL23668120 | 0.83 | CAPN1 (0.43) | NTSR1NPY2RNPY4RNPY5RNPY1R | |
| Larazotide SCHEMBL28795844 | 0.83 | CAPN1 (0.43) | NTSR1NPY2RNPY4RNPY5RNPY1R | |
| Larazotide SCHEMBL23668121 | 0.83 | CAPN1 (0.43) | NTSR1NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29407973 | 0.83 | F2 (0.50) | NTSR1F2NPY2RNPY4RNPY5R | |
| SCHEMBL30432780 | 0.82 | F2 (0.53) | F2NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31196712 | 0.82 | NPY2R (0.53) | NTSR1NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30978825 | 0.82 | BACE1 (0.50) | NTSR1F2NPY2RNPY4RNPY5R | |
| SCHEMBL29387855 | 0.82 | NPY2R (0.56) | NTSR1NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31226869 | 0.82 | NTSR1 (0.60) | NTSR1F2NTSR2OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114053165-B | Use of biologically active substances for producing a composition for improving the condition of the skin | 大江生医股份有限公司 | 2023-10-20 | — | — | CN | disclosed |
| US-11400138-B2 | Method for improving skin condition with bioactive compound | TCI CO., LTD. (TW) | 2022-08-02 | — | — | US | disclosed |